ClinicalTrials.govpublic full text
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
platinum resistant ovarian cancer, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909761
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.